First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences
- PMID: 32659712
- PMCID: PMC7336937
- DOI: 10.1016/j.jcv.2020.104537
First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences
Abstract
Background: Broad and decentralised testing of SARS-CoV-2 RNA genomes is a WHO-recommended strategy to contain the SARS-CoV-2 pandemic by identifying infected cases in order to minimize onward transmission. With the need to increase the test capacities in Austria, nation-wide numerous laboratories rapidly implemented assays for molecular detection of SARS-CoV-2 based on real-time RT-PCR assays. The objective of this study was to monitor reliability of the laboratory results for SARS-CoV-2 RNA detection through an external quality assessment (EQA) scheme.
Methods: For this, the Center for Virology, Medical University of Vienna was tasked by the Federal Ministry of Social Affairs, Health, Care and Consumer Protection to perform the first Austrian EQA on SARS-CoV-2 which was organised in cooperation with the Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests (ÖQUASTA). Data were analysed on the basis of qualitative outcome of testing in relation to the nucleic acid (NA) extraction and detection methods used.
Results and conclusion: A total of 52 laboratories participated, contributing results from 67 test panels comprising 42 distinct combinations of NA extraction and PCR reagents. By testing 3 positive (CT values: S1, 28.4; S2, 33.6; S3, 38.5) and 1 negative sample, no false-positive results were obtained by any of the laboratories. Otherwise, 40/67 tests (60 %) detected all positive samples correctly as positive, but 25/67 tests (37 %) did not detect the weakest positive sample (S3), and 3 % reported S2 and S3 as false-negative. Improvement in test sensitivity by focusing on NA extraction and/or PCR-based detection is recommended.
Keywords: COVID-19 pandemic; Evaluation; External quality assessment; Molecular test; SARS-CoV-2; Standardisation.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The Authors have no conflicts of interest to declare.
Figures
Similar articles
-
Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea.Emerg Infect Dis. 2020 Oct;26(10):2353-2360. doi: 10.3201/eid2610.202551. Epub 2020 Jul 29. Emerg Infect Dis. 2020. PMID: 32723432 Free PMC article.
-
International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020.Euro Surveill. 2020 Jul;25(27):2001223. doi: 10.2807/1560-7917.ES.2020.25.27.2001223. Euro Surveill. 2020. PMID: 32672149 Free PMC article.
-
Pooled testing for COVID-19 diagnosis by real-time RT-PCR: A multi-site comparative evaluation of 5- & 10-sample pooling.Indian J Med Res. 2020 Jul & Aug;152(1 & 2):88-94. doi: 10.4103/ijmr.IJMR_2304_20. Indian J Med Res. 2020. PMID: 32893844 Free PMC article.
-
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
-
Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA.J Clin Microbiol. 2020 Jul 23;58(8):e00796-20. doi: 10.1128/JCM.00796-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32381642 Free PMC article. Review.
Cited by
-
Interlaboratory comparison of SARS-CoV2 molecular detection assays in use by U.S. veterinary diagnostic laboratories.J Vet Diagn Invest. 2021 Nov;33(6):1039-1051. doi: 10.1177/10406387211029913. Epub 2021 Jul 23. J Vet Diagn Invest. 2021. PMID: 34293974 Free PMC article.
-
Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA).Clin Chem Lab Med. 2025 Jan 6;63(5):898-915. doi: 10.1515/cclm-2024-1293. Print 2025 Apr 28. Clin Chem Lab Med. 2025. PMID: 39753240 Review.
-
Converting to an international unit system improves harmonization of results for SARS-CoV-2 quantification: Results from multiple external quality assessments.J Clin Virol. 2023 Jan;158:105352. doi: 10.1016/j.jcv.2022.105352. Epub 2022 Dec 10. J Clin Virol. 2023. PMID: 36525853 Free PMC article.
-
Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients.Int J Infect Dis. 2021 Apr;105:144-146. doi: 10.1016/j.ijid.2021.02.052. Epub 2021 Feb 17. Int J Infect Dis. 2021. PMID: 33609774 Free PMC article.
-
High quality of SARS-CoV-2 molecular diagnostics in a diverse laboratory landscape through supported benchmark testing and External Quality Assessment.Sci Rep. 2024 Jan 16;14(1):1378. doi: 10.1038/s41598-023-50912-9. Sci Rep. 2024. PMID: 38228693 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous